Summit Creek Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Creek Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$8,336,000
+19.6%
131,860
+0.4%
0.94%
+34.9%
Q4 2021$6,967,000
-22.8%
131,357
+2.8%
0.70%
-26.6%
Q3 2021$9,020,000
+15.6%
127,783
+9.2%
0.95%
+2.4%
Q2 2021$7,800,000
-42.1%
117,047
-3.6%
0.93%
-42.0%
Q1 2021$13,472,000
-7.7%
121,362
-1.3%
1.61%
-14.3%
Q4 2020$14,600,000
+28.2%
122,950
-5.8%
1.87%
+10.8%
Q3 2020$11,387,000
-0.4%
130,510
+2.3%
1.69%
+0.4%
Q2 2020$11,428,000127,6001.68%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders